CCXI - ChemoCentryx Inc. (CCXI) CEO Dr. Thomas Schall on Q1 2022 Results - Earnings Call Transcript

ChemoCentryx, Inc. (CCXI) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 PM ET Company Participants Dr. Thomas Schall – Chairman, President and Chief Executive Officer Tausif Butt – Executive Vice President, Chief Operating Officer Susan Kanaya – Executive Vice President, Chief Financial and Administrative Officer Bill Slattery, Jr. – Vice President of Investor Relations & Corporate Communications Conference Call Participants Joseph P. Schwartz – SVB Leerink Ryan Deschner – Raymond James Yanan Zhu – Wells Fargo Securities Dae Gon Ha – Stifel Nicolaus Anupam Rama – J.P. Morgan Michelle Gilson – Canaccord Genuity Group Inc. Edward White – H.C. Wainwright Presentation Operator Good afternoon and welcome to the ChemoCentryx First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conclude -- we would conduct a question and answer session. As a reminder, this conference call will be recorded. I

For further details see:

ChemoCentryx, Inc. (CCXI) CEO Dr. Thomas Schall on Q1 2022 Results - Earnings Call Transcript